A detailed history of Deseret Mutual Benefit Administrators transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Deseret Mutual Benefit Administrators holds 11,981 shares of BMY stock, worth $686,870. This represents 0.32% of its overall portfolio holdings.

Number of Shares
11,981
Previous 11,326 5.78%
Holding current value
$686,870
Previous $470,000 31.91%
% of portfolio
0.32%
Previous 0.22%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$39.66 - $51.75 $25,977 - $33,896
655 Added 5.78%
11,981 $620,000
Q2 2024

Aug 02, 2024

BUY
$40.25 - $52.99 $35,943 - $47,320
893 Added 8.56%
11,326 $470,000
Q1 2024

May 09, 2024

BUY
$47.98 - $54.4 $38,048 - $43,139
793 Added 8.23%
10,433 $565,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $87,070 - $103,898
-1,796 Reduced 15.7%
9,640 $494,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $46,833 - $52,366
-809 Reduced 6.61%
11,436 $663,000
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $41,220 - $45,768
647 Added 5.58%
12,245 $783,000
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $3,154 - $3,577
-48 Reduced 0.41%
11,598 $803,000
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $592,488 - $701,590
-8,652 Reduced 42.62%
11,646 $837,000
Q3 2022

Nov 03, 2022

SELL
$0.13 - $76.84 $627 - $371,060
-4,829 Reduced 19.22%
20,298 $1.44 Million
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $15,613 - $17,195
-215 Reduced 0.85%
25,127 $1.94 Million
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $188,005 - $225,435
-3,058 Reduced 10.77%
25,342 $1.85 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $121,471 - $141,607
2,265 Added 8.67%
28,400 $1.77 Million
Q3 2021

Nov 04, 2021

BUY
$59.17 - $69.31 $919,738 - $1.08 Million
15,544 Added 146.77%
26,135 $1.55 Million
Q2 2021

Aug 06, 2021

BUY
$61.91 - $67.42 $655,688 - $714,045
10,591 New
10,591 $708,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Deseret Mutual Benefit Administrators Portfolio

Follow Deseret Mutual Benefit Administrators and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deseret Mutual Benefit Administrators, based on Form 13F filings with the SEC.

News

Stay updated on Deseret Mutual Benefit Administrators with notifications on news.